Mufg Securities Americas Inc. Buys Shares of 13,585 UnitedHealth Group Incorporated (NYSE:UNH)

Mufg Securities Americas Inc. acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 13,585 shares of the healthcare conglomerate’s stock, valued at approximately $6,872,000. UnitedHealth Group makes up about 0.9% of Mufg Securities Americas Inc.’s investment portfolio, making the stock its 19th biggest position.

Several other hedge funds also recently added to or reduced their stakes in UNH. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group during the 4th quarter valued at about $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter worth about $28,000. AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $30,000. Finally, Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group during the 4th quarter worth approximately $30,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of UNH opened at $311.23 on Wednesday. The firm has a market capitalization of $282.33 billion, a PE ratio of 20.08, a P/E/G ratio of 1.37 and a beta of 0.56. The stock’s 50 day moving average is $482.53 and its two-hundred day moving average is $519.28. UnitedHealth Group Incorporated has a twelve month low of $309.10 and a twelve month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the business posted $6.91 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 2.70%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.18%.

Wall Street Analyst Weigh In

UNH has been the topic of several recent research reports. Raymond James reaffirmed a “strong-buy” rating and issued a $540.00 price target (down from $635.00) on shares of UnitedHealth Group in a report on Monday, April 21st. Morgan Stanley reduced their price target on UnitedHealth Group from $664.00 to $563.00 and set an “overweight” rating for the company in a research report on Tuesday, April 22nd. Robert W. Baird lowered their price objective on UnitedHealth Group from $640.00 to $510.00 and set an “outperform” rating on the stock in a research report on Tuesday, April 29th. Truist Financial lowered their price target on shares of UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating on the stock in a report on Monday, April 21st. Finally, Barclays decreased their price objective on shares of UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating for the company in a research report on Monday, April 21st. Four investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average price target of $596.86.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.